Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.

Whitburn J. et al, (2022), Sci Adv, 8

Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.

Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546

A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.

Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369

Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.

Farolfi A. et al, (2021), Eur Urol Oncol

Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.

Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

Huynh-Le M-P. et al, (2021), Nat Commun, 12

The effect of sample size on polygenic hazard models for prostate cancer.

Karunamuni RA. et al, (2020), Eur J Hum Genet, 28, 1467 - 1475

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.

Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev, 29, 1731 - 1738

Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].

Neal DE. et al, (2020), Eur Urol, 78, e139 - e143

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.

Philippou Y. et al, (2020), Br J Cancer, 123, 1089 - 1100

Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Sathianathen NJ. et al, (2020), Eur Urol, 78, 402 - 414

Glutamine deprivation alters the origin and function of cancer cell exosomes.

Fan S-J. et al, (2020), EMBO J, 39

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Cappuccini F. et al, (2020), J Immunother Cancer, 8

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.

Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.

Harrison S. et al, (2020), Cancer Causes Control, 31, 431 - 449

Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect.

Lovegrove CE. et al, (2020), BJU Int, 125, 484 - 486

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.

Bryant RJ. et al, (2020), BJU Int, 125, 506 - 514

Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines).

Beard DJ. et al, (2020), Lancet, 395, 828 - 838

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.

Neal DE. et al, (2020), Eur Urol, 77, 320 - 330

Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis.

Rao SR. et al, (2020), Front Oncol, 10

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?